Friday, 29 October 2021
  
Login

Australia's most trusted
source of pharma news

Friday, 29 October 2021
News

Two Covid drugs hit review list

Posted 24 September 2021 AM

Covid therapies developed by MSD and Roche are among seven new medicines that have been accepted for review by the TGA this month.

The regulator revealed it is currently reviewing Roche's antibody cocktail Ronapreve and MSD's oral antiviral molnupiravir with its local brand name still "to be confirmed" via the provisional approval pathway.

To see the whole article, please login

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read. If you don't have a password, just enter your email address and then click Login.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 
 
 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.